Accelerating ALS Research (IMAGE)

New York Genome Center

Accelerating ALS Research

Caption

The Center for Genomics of Neurodegenerative Disease (CGND) at the New York Genome Center (NYGC) combines the expertise of NYGC scientists and its global partners to translate its genomic research into innovative advancements in clinical care and accelerate the development of new ALS treatments. Through initiating and fostering many critical collaborations, ALS data sharing increased on a large scale, empowering an integrative worldwide approach to find effective treatments and a cure for ALS. NYGC's CGND is led by its Director, Hemali Phatnani, Ph.D., (pictured, seated, with her lab team).

Credit

New York Genome Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.